Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Dear Members, The early bird registration deadline for CBS 2023 in Halifax has been extended to April 21st, 2023 To register, click here...

Dear Members, The abstract submission deadline for CBS 2023 in Halifax has been extended to March 17th, 2023 Please click here to learn more...

The Exploration of Biomat-X EBMX invites you to submit your next original contribution to the inaugural edition of this journal to help the journal positioning itself among the major players in the field...

Dear Members, Reistration for CBS 2023 at Dalhousie University in Halifax, NS is officially open You can register here...

Systemic adoptive T lymphocyte transfer is an emerging cancer immunotherapy showing tremendous promise in clinical studies, and its success lies in the ability of the antigen-experienced cytotoxic T lymphocytes cTL to access and to persist in the tumour microenvironment 1 ...

Significant bone loss due to internal or external factors remains a large orthopedic challenge. Current interventions use either autograft or allograft sources that carry a significant complication burden and show limited functional recovery, emphasizing the demand for an alternative therapeutic solution...

Back pain is the leading cause of disability worldwide affecting the well-being of more than 80 of the adult population in industrialized countries...

Tendon tissues possess an ineffective intrinsic healing mechanism, owing to their low vascularity and hypocellularity1...

Prevention of biofilm formation is a key factor when developing bone-interfacing biomaterials to reduce the spread of bacterial infections and the need for antibiotic treatment 1 ...